RUNX2 and melanoma: We show that when the five PRT lines derived from the PLX4720-resistant 1205LU melanoma xenografts are treated in vitro with PLX4720, all PRT lines exhibit an increased RUNX2 expression (isoforms 2/3) as compared with vehicle-treated cells.